The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chutko L.S.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Surushkina S.Yu.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Iakovenko E.A.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg

Rozhkova A.V.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg

Anisimova T.I.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Bondarchuk Iu.L.

Institut mozga cheloveka im. N.P. Bekhterevoĭ Rossiĭskoĭ akademii nauk, Sankt-Peterburg

The efficacy of cytoflavin in the treatment of burnout syndrome

Authors:

Chutko L.S., Surushkina S.Yu., Iakovenko E.A., Rozhkova A.V., Anisimova T.I., Bondarchuk Iu.L.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(10): 66‑70

DOI: 10.17116/jnevro201511510166-70

Views: 956

Downloaded: 15

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Chutko LS, Surushkina SYu, Iakovenko EA, Rozhkova AV, Anisimova TI, Bondarchuk IuL. The efficacy of cytoflavin in the treatment of burnout syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(10):66‑70. (In Russ.)
https://doi.org/10.17116/jnevro201511510166-70

 
МСФ на ЯМ
Close metadata
Recommended articles:
Asthenic diso­rders correction with Reco­gnan. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):57-62
Factors of the hemo­stasis system as biomarkers of severe course of acute viral infe­ctions. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):63-74
Resu­lts of a cohort single-center randomized study of the modu­lating effect of the drug Mexi­dol in the reha­bilitation of patients who suffered acute cere­bral insu­fficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):108-117
Cognitive impairment in patients with arte­rial hype­rtension. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):41-48
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Reco­gnan (citicoline) in the correction of asthenic and anxiety-depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):43-47
Severe traumatic brain injury with damage to the posterior cranial fossa in a teenager. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8):113-117
Chro­nic fati­gue syndrome in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):28-33
Possibilities of using cyto­protectors in complex therapy of chro­nic coro­nary heart disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(4):410-419
Ethy­lmethylhydroxypyridine succinate enha­nces analgesic effect of cyclooxygenase inhi­bitors in rats with postoperative hype­ralgesia. Russian Journal of Pain. 2024;(3):5-11

Objective. To evaluate the efficacy of cytoflavin in the treatment of patients with burnout syndrome. Material and methods. Authors performed clinical, psychological and neurophysiological examinations of 60 patients, aged 34—43 years. Results of pharmacological therapy with cytoflavin (30 patients) or ethylmethylhydroxypyridine succinate (30 patients) were compared. Control examination was conducted immediately after treatment and then after 30 days to assess the stability of the resulting effect. Results and conclusion. The higher efficacy of cytoflavin (improvement in 80% of cases) as compared to ethylmethylhydroxypyridine succinate (improvement in 70% of cases) was identified. After cytoflavin treatment, the improvement was more persistent. These clinical results are confirmed by the results of psychological and neurophysiological research.

Keywords:

burnout syndrome
asthenia
fatigue
cytoflavin
ethylmethylhydroxypyridine succinate

Authors:

Chutko L.S.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Surushkina S.Yu.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Iakovenko E.A.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg

Rozhkova A.V.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg

Anisimova T.I.

Institut mozga cheloveka RAN im. N.P. Bekhterevoĭ, Sankt-Peterburg;
Sankt-Peterburgskaia gosudarstvennaia pediatricheskaia meditsinskaia akademiia

Bondarchuk Iu.L.

Institut mozga cheloveka im. N.P. Bekhterevoĭ Rossiĭskoĭ akademii nauk, Sankt-Peterburg

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.